---
$id: https://graph.org.ai/products/commodity/51271615
$type: Product
source: UNSPSC
code: "51271615"
title: "Oxetacaine or oxethazaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxetacaine or oxethazaine

**UNSPSC Code**: 51271615
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C28H41N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IP8QT76V17, chemically known as 2,2-((2-hydroxyethyl)imino)bis(n-(alpha,alpha-dimethylphenethyl)-n-methylacetamide) but generally known as oxetacaine, which bears US NIH Compound Identifier 4621. European Medicines Agency schedules Oxetacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09516MIG. The term OXETACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules oxetacaine in its Anatomical Therapeutic Chemical (ATC) Classification. OXETACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Oxetacaine or oxethazaine bears US NLM identifiers UMLS ID C0069758 and NCI Concept Code C81409. SMILES: O=C(N(C(CC1CCCCC1)(C)C)C)CN(CC(=O)N(C(CC1CCCCC1)(C)C)C)CCO.

